LastMile – improving through digital LastMile – improving through digital LastMile initiative is an integrated, solutions-driven program seeking to make animal medical resources available in hard-to-reach areas in Africa.
Classical Swine Fever live vaccine approved in China Classical Swine Fever live vaccine approved in China Boehringer Ingelheim’s China-developed Classical Swine Fever live vaccine approved
Veterinary oncology experts meet in Germany Veterinary oncology experts meet in Germany Veterinary oncology experts meet prior to the European Society of Veterinary Oncology Congress in Hofheim, Germany
Positive-CHMP-opinion-for-dabigatran-in-children Positive-CHMP-opinion-for-dabigatran-in-children Positive CHMP opinion received for use of dabigatran for the treatment and prevention of venous thromboembolic events in children
NexGard COMBO for cats EMA marketing authorization NexGard COMBO for cats EMA marketing authorization Boehringer Ingelheim received marketing authorization from the EMA (European Medicine Agency) for its NexGard® COMBO topical solution for cats.
BIVF funding more than doubled to 250 M€ BIVF funding more than doubled to 250 M€ Boehringer Ingelheim increases funding for its corporate venture fund, the Boehringer Ingelheim Venture Fund (BIVF), from EUR 100 to 250 million
Purevax range now available in 0.5 ml presentation Purevax range now available in 0.5 ml presentation Boehringer Ingelheim announces reduced volume 0.5 ml Purevax vaccines for cats, more convenient vaccination experience combined with same efficacy
cystic fibrosis phase II trial cystic fibrosis phase II trial The first patient has been enrolled in a phase II trial to evaluate an innovative treatment for cystic fibrosis, inhaled via the Respimat® inhaler
Aservo EquiHaler wins Red Dot 2020 for design quality Aservo EquiHaler wins Red Dot 2020 for design quality Aservo EquiHaler wins a prestigious Red Dot Award 2020 for outstanding design quality
Behavioral science to improve cattle well-being Behavioral science to improve cattle well-being Boehringer Ingelheim kicks off a project based on behavioral science to improve cattle well-being
Soaring to save lives Soaring to save lives Tackling health disparities through drone delivery of vaccines animals and livestock living in underserved communities
commitments to sustainable development commitments to sustainable development On One Health Day, Boehringer Ingelheim shares an update on its strategic approach to sustainability for employees, partners and wider communities
Netherton syndrome (NS) Netherton syndrome (NS) Information on Netherton syndrome (NS), a severe, ultra-rare multisystem disorder which has a life-altering impact across a person’s life.
“Rapid progress towards clinical candidates” “Rapid progress towards clinical candidates” Boehringer Ingelheim forms a joint venture to create the next generation of antimicrobials.
Your dog’s life stages: dog health from puppy to adult and senior Your dog’s life stages: dog health from puppy to adult and senior The needs of dogs change as they age. Find out how to take care of their health at all stages of life: from puppy to adult and senior.
Fast-Track-Designation-NASH Fast-Track-Designation-NASH Boehringer Ingelheim and Zealand Pharma announced that the FDA granted Fast Track Designation to the dual agonist BI 456906 for adults with NASH.
Research-collaboration-Gubra-obesity-treatment Research-collaboration-Gubra-obesity-treatment Boehringer Ingelheim and Gubra enter collaboration to identify and validate targets and innovative peptides for the treatment of obesity.
Advance study vaccinating increased milk production Advance study vaccinating increased milk production [New ADVANCE study shows vaccinating with Bovela® results in increased milk production
collaboration-LIBD collaboration-LIBD Boehringer Ingelheim and The Lieber Institute for Brain Development collaborate on centrally acting COMT inhibitors in neuropsychiatric disorders
InPedILD_trial_enrollment InPedILD_trial_enrollment First patient enrolled in InPedILD™, a global Phase III trial assessing the dosing and safety profile of nintedanib in children and adolescents
Perceived burden of COPD is higher for younger patients Perceived burden of COPD is higher for younger patients New global survey reveals perceived burden of disease is greater in younger people living with COPD
BI_PharmAccess_launch_digital_healthcare_program BI_PharmAccess_launch_digital_healthcare_program Boehringer Ingelheim and PharmAccess launch a new mobile support program „Tiba Yako“ to empower patients to become more aware, access care and take charge of their disease management
FOYA_Shanghai FOYA_Shanghai Boehringer Ingelheim’s commercial manufacturing facility in Shanghai has been awarded as “Facility of the Year”
Making sustainable medicines through eco-design Making sustainable medicines through eco-design Our goal is to minimize the environmental footprint of our medicines through integration of eco-design and green chemistry across the entire lifecycle
Ukraine Help: We fly, we bike, we accommodate Ukraine Help: We fly, we bike, we accommodate The solidarity for Ukraine from Boehringer Ingelheim employees is incredible. Equally impressive is their practical help.